🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 48 of 200 · A–Z by INN

  1. daclatasvir dihydrochloride

    DAKLINZA

    ORAL FDA: approved

  2. daclatasvir hydrochloride

    DAKLINZA

    PMDA: approved

  3. daclatasvir hydrochloride/ asunaprevir/beclabuvir hydrochloride

    XIMENCY

    PMDA: approved

  4. daclizumab

    ZENAPAX

    INJECTION FDA: approved · EMA: withdrawn

    L04AC01

  5. dacomitinib

    VIZIMPRO

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    L01EB07

  6. dacomitinib hydrate

    VIZIMPRO

    PMDA: approved

  7. dactinomycin

    DACTINOMYCIN Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  8. dalbavancin

    XYDALBA

    EMA: approved

    J01XA04

  9. dalbavancin hydrochloride

    DALBAVANCIN HYDROCHLORIDE Teva Pharma GmbH

    INTRAVENOUS FDA: approved

  10. dalfampridine

    DALFAMPRIDINE Teva Pharma GmbH

    ORAL FDA: approved

  11. dalfopristin

    SYNERCID

    INTRAVENOUS FDA: approved

  12. dalteparin sodium

    FRAGMIN

    INJECTION FDA: approved

  13. damoctocog alfa pegol

    JIVI

    EMA: approved · PMDA: approved

    B02BD02

  14. danaparoid sodium

    ORGARAN

    INJECTION FDA: approved

  15. danazol

    DANOCRINE Beam Therapeutics

    ORAL FDA: approved

  16. danicopan

    VOYDEYA

    ORAL FDA: approved · EMA: approved · PMDA: approved

    L04AJ09

  17. dantrolene

    DANTRIUM Pfizer Australia Pty Ltd

    TGA: approved

  18. dantrolene sodium

    DANTRIUM ELITE PHARMACEUTICALS INC /NV/

    INJECTION FDA: approved

  19. dantrolene sodium, hemiheptahydrate

    AGILUS

    EMA: approved

    M03CA01

  20. dapagliflozin

    FORXIGA AstraZeneca

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    A10BK01

  21. dapagliflozin + metformin

    XIGDUO XR 5/1000 AstraZeneca

    TGA: approved

  22. dapagliflozin + sitagliptin

    SIDAPVIA 10/100 AstraZeneca

    TGA: approved

  23. dapagliflozin propylene glycolate hydrate

    FORXIGA INITIAL APPROVAL

    PMDA: approved

  24. dapagliflozin || metformin

    DAPAGLIFLOZIN AND METFORMIN

    FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources